BioCentury
ARTICLE | Company News

Integra LifeSciences Corp. other research news

November 10, 1997 8:00 AM UTC

IART subsidiary Telios Pharmaceuticals Inc. (San Diego, Calif.) received a $96,500 grant from the National Cancer Institute to develop an RGD-based compound to inhibit angiogenesis by binding the cel...